Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2011-05-31 12:44:31
Reporting Period:
Filing Date:
Accepted Time:
2011-05-31 12:44:31
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
819050 Vical Inc VICL Biological Products, (No Disgnostic Substances) (2836) 930948554
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1049372 H Robert Campbell 10390 Pacific Center Court
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock $.01 Par Value Acquisiton 2011-05-26 18,750 $0.01 51,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $.01 Par Value Nonstatutory Stock Option (right to buy) Acquisiton 2011-05-26 56,250 $0.00 56,250 $3.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
232,500 2012-05-26 2021-05-26 No 4 A Direct
  1. Shares were acquired pursuant to a restricted stock grant.
  2. The date in this field is approximate. These options are exercisable at the date of the next annual meeting of stockholders. The date of the meeting has not been set, but is expected to occur in May 2012.
  3. This balance includes 18,750 of unvested restricted stock units.